Anti-ERBB3/HER3 Antibody (Patritumab)
Catalog No.
F1430
Anti-ERBB3/HER3 Antibody (Patritumab)
Featured Products
Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody against ERBB3. Patritumab has a synergistic effect with Cetuximab and can effectively inhibit the phosphorylation of EGFR, HER2, HER3, ERK and AKT. Patritumab can also induce apoptosis and inhibit the growth of pancreatic, non-small cell lung cancer and colorectal cancer xenograft tumors.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.86 kDa
Dry ice
1262787-83-6
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
U3-1287, AMG-888
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P21860
Human, Rat
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human HER3 His at 2 ug/mL can bind Anti-ERBB3/HER3 Antibody (Patritumab)
ERBB3 / HER3
Please avoid freeze-thaw cycles.